AI Market Mood: Stock Dashboard
AVXL
Fundamental
Company: Anavex Life Sciences Corporation
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -0.55
Insider Own: 3.30%
Shs Outstand: 84.99M
Perf Week: 4.42%
Market Cap: 783.44M
Forward P/E: 6.98
EPS next Y: 1.32
Insider Trans: 0.00%
Shs Float: 82.26M
Perf Month: -5.44%
Income: -46.49M
PEG: -
EPS next Q: -0.15
Inst Own: 34.59%
Short Float: 29.89%
Perf Quarter: -6.50%
Sales: 0.00M
P/S: -
EPS this Y: -22.44%
Inst Trans: 10.30%
Short Ratio: 22.51
Perf Half Y: 67.30%
Book/sh: 1.31
P/B: 7.06
EPS next Y Percentage: 307.33%
ROA: -34.17%
Short Interest: 24.59M
Perf Year: 142.37%
Cash/sh: 1.42
P/C: 6.49
EPS next 5Y: -
ROE: -37.72%
52W Range From: 3.25
52W Range To: 14.44
Perf YTD: -14.25%
Dividend Est.: -
P/FCF: -
EPS past 5Y: 0.85%
ROI: -41.92%
52W High: -36.22%
Beta: 0.79
Dividend TTM: -
Quick Ratio: 9.45
Sales past 5Y: 0.00%
Gross Margin: -
52W Low: 183.38%
ATR (14): 0.64
Dividend Ex-Date: -
Current Ratio: 9.45
EPS Y/Y TTM: -3.08%
Oper. Margin: -
RSI (14): 54.85
Volatility W: 5.25%
Volatility M: 8.33%
Employees: 42
Debt/Eq: 0.00
Sales Y/Y TTM: -
Profit Margin: -
Recom: 1.00
Target Price: 34.33
Option/Short: Yes / Yes
LT Debt/Eq: 0.00
EPS Q/Q: -36.00%
Payout: -
Rel Volume: 0.64
Prev Close: 8.76
Sales Surprise: -
EPS Surprise: 17.65%
Sales Q/Q: -
Earnings: Feb 12 BMO
Avg Volume: 1.09M
Price: 9.21
SMA20: 5.51%
SMA50: 5.26%
SMA200: 19.26%
Trades:
Volume: 694,510
Change: 5.14%
Technical:
Latest News:
Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference neutral
ANVS AVXL LGVN
Summary: Annovis Bio Inc. will participate in the H.C. Wainwright 26th Annual Global Investment Conference with a company presentation by Dr. Maccecchini discussing recent advancements and strategic direction, followed by a panel discussion on innovative non-amyloid approaches in Alzheimer’s disease.
Full article2024-09-05T13:33:22Z